Novelstem International Corp NSTM:OTCPK

RT Quote | Exchange | USD
Last | 03/03/21 EST
0.2048UNCH (UNCH)
52 week range
0.05 - 0.30

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.2048
  • 52 Week High0.30
  • 52 Week High Date02/17/21
  • 52 Week Low0.05
  • 52 Week Low Date09/10/20
  • Market Cap3.30M
  • Shares Out16.13M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.07
  • 1 Year % Change70.67

RATIOS/PROFITABILITY

  • EPS (TTM)0.28
  • P/E (TTM)0.74
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-4.814M
  • ROE (MRQ)22.72%
  • Revenue (MRQ)420,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)1,472.12%
  • Debt To Equity (MRQ)0.11%

EVENTS

  • Earnings Date-
  • Ex Div Date03/22/2018
  • Div Amount0.45
  • Split Date-
  • Split Factor-

Latest Novelstem International Corp News

There is no recent news for this security.

Latest NSTM News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Novelstem International Corp., formerly Hollywood Media Corp., provides Stem Cell-Based Diagnostic technology. The Company has developed diagnostic technology that can predict patients’ resistance to chemotherapy to allow for better, targeted cancer treatments with the potential to reduce incidents of chemotherapy resistance. The Company’s diagnostic solutions are based on the research of human haploid pluripoten and enables informed, personalized selection of chemotherapy...
Jan Loeb
Chairman
Address
2255 Glades Rd Ste 221A
Boca Raton, FL
33431-8547
United States